- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Surgical checklist adherence across urology expertise levels impacts TURBT quality indicators.
October 24, 2022
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.
October 21, 2022
Neoadjuvant Nivolumab plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.
October 21, 2022
Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific.
October 20, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer.
October 20, 2022
Activation of cGAS-STING in Bladder Cancer by Cisplatin Chemotherapy - Expert Commentary
October 19, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention.
October 19, 2022
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.
October 19, 2022
Analysis of Complications after Robot-Assisted Radical Cystectomy between 2002-2021.
October 18, 2022
Role of MIF1/MIF2/CD74 interactions in bladder cancer.
October 17, 2022
Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: A case-control study.
October 14, 2022
Ancestry-Driven Recalibration of Tumor Mutational Burden as a Biomarker of Response to Immune Checkpoint Inhibitors - Expert Commentary
October 13, 2022
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety Profile.
October 13, 2022
